BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8443393)

  • 1. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
    Uckun FM; Song CW
    Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.
    Uckun FM; Aeppli D; Song CW
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):899-906. PubMed ID: 8244821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.
    Uckun FM; Jaszcz W; Chandan-Langlie M; Waddick KG; Gajl-Peczalska K; Song CW
    J Clin Invest; 1993 Mar; 91(3):1044-51. PubMed ID: 8450034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Ramsay NK; Waddick KG; Jaszcz W; Chandan-Langlie M; Obuz V; Haake R; Gajl-Peczalska K; Kersey JH; Song CW
    Blood; 1991 Dec; 78(11):2945-55. PubMed ID: 1835411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma.
    Uckun FM; Song CW; Nesbit M; Kersey JH; Ramsay NK
    Int J Radiat Oncol Biol Phys; 1992; 24(4):705-12. PubMed ID: 1429095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia.
    Uckun FM; Chandan-Langlie M; Jaszcz W; Obuz V; Waddick K; Song CW
    Cancer Res; 1993 Mar; 53(6):1431-6. PubMed ID: 8443821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the CD19 receptor on human B-lineage leukemia cells activates LCK tyrosine kinase and facilitates radiation-induced apoptosis.
    Waddick KG; Chae HP; Tuel-Ahlgren L; Jarvis LJ; Dibirdik I; Myers DE; Uckun FM
    Radiat Res; 1993 Dec; 136(3):313-9. PubMed ID: 7506428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.
    Uckun FM; Chandan-Langlie M; Dockham PA; Aeppli D; Sladek NE
    Leuk Lymphoma; 1994 May; 13(5-6):417-28. PubMed ID: 8069187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting.
    Mikhailova E; Itov A; Zerkalenkova E; Roumiantseva J; Olshanskaya Y; Karachunskiy A; Novichkova G; Maschan M; Popov A
    Cytometry B Clin Cytom; 2022 Sep; 102(5):353-359. PubMed ID: 35796438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
    De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
    Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
    Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
    Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.
    Gattei V; Aldinucci D; Attadia V; Degan M; Alosi MS; De Iuliis A; Babare R; Rossi FM; Rupolo M; Zagonel V; Pinto A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):141-51. PubMed ID: 9426972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
    Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
    Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
    Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
    Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
    Chatterjee G; Dhende P; Raj S; Shetty V; Ghogale S; Deshpande N; Girase K; Patil J; Kalra A; Narula G; Dalvi K; Dhamne C; Moulik NR; Rajpal S; Patkar NV; Banavali S; Gujral S; Subramanian PG; Tembhare PR
    Eur J Haematol; 2024 Jan; 112(1):122-136. PubMed ID: 37706583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia.
    Uckun FM; Song CW
    Cancer Res; 1988 Oct; 48(20):5788-95. PubMed ID: 3262412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.